Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

22.83
Delayed Data
As of Mar 27
 -1.12 / -4.68%
Today’s Change
19.45
Today|||52-Week Range
33.60
-9.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$732.4M

Company Description

Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products. With a primary focus on generic injectable pharmaceuticals, the company offers its customers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes and premix bags. Sagent Pharmaceuticals was founded by Jeffrey M. Yordon on January 26, 2006 and is headquartered in Schaumburg, IL.

Contact Information

Sagent Pharmaceuticals, Inc.
1901 North Roselle Road
Schaumburg Illinois 60195
P:(847) 908-1600
Investor Relations:
(847) 908-1605

Employees

Shareholders

Individual stakeholders58.68%
Mutual fund holders43.58%
Other institutional33.28%

Top Executives

Jonathon M. SingerChief Financial Officer & Executive Vice President
Ravi MalhotraChief Scientific Officer
Michael LogerfoSecretary, Chief Legal Officer & Executive VP
Jeffrey W. GreveVice President & Controller
Lorin DrakeVice President-Sales

To view my watchlist

Not a member yet?

Sign up now for a free account